mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.064 |
0.3 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.3 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.3 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.3 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |